Eurofins Scientific SE Stock
Stocks
ERF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.02 EUR | +2.73% |
|
+7.16% | +7.40% |
| 06-04 | Eurofins Scientific SE acquired High North Laboratories. | CI |
| 05-14 | Eurofins Scientific SE Develops And Offers New Solutions For Hantavirus Detection | CI |
| Market Cap | 11.71B 13.3B 10.8B 10.1B 18.93B 1,254B 19.28B 130B 50.28B 619B 49.95B 48.86B 2,152B | P/E 2026 * |
23.3x | P/E 2027 * | 17.9x |
|---|---|---|---|---|---|
| Enterprise Value | 15.15B 17.21B 13.98B 13.07B 24.49B 1,622B 24.95B 168B 65.06B 800B 64.62B 63.22B 2,784B | EV / Sales 2026 * |
1.99x | EV / Sales 2027 * | 1.83x |
| Free-Float |
58.35% | Yield 2026 * |
1.15% | Yield 2027 * | 1.34% |
Last Transcript: Eurofins Scientific SE
| 1 day | +2.73% | ||
| 1 week | +7.16% | ||
| Current month | +7.30% | ||
| 1 month | +7.09% | ||
| 3 months | +9.87% | ||
| 6 months | +7.85% | ||
| Current year | +7.40% |
| 1 week | 62.16 |  | 67.36 |
| 1 month | 60.76 | | 67.36 |
| Current year | 56.84 | | 74.32 |
| 1 year | 54.86 | | 74.32 |
| 3 years | 39.47 | | 74.32 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 29.82 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 1986-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 2014-12-31 |
Christian Wurst
PRN | Corporate Officer/Principal | 53 | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 1986-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 2014-12-31 |
Valérie Hanote
BRD | Director/Board Member | 60 | 1989-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-26 | Buy | 700 | 0.0004% | |||
| 04-18 | Sell | Chief Financial Officer | 3,000 | 0.0016% | ||
| 04-18 | Sell | Chief Financial Officer | 3,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.73% | +7.16% | +11.00% | +18.45% | 12.98B | |
| +2.56% | +7.12% | -7.30% | -0.26% | 44.45B | |
| +0.15% | +7.61% | +324.11% | +565.24% | 36.04B | |
| +0.36% | +5.50% | +3.87% | +54.57% | 30.7B | |
| +8.37% | +8.76% | +17.05% | -13.29% | 28.59B | |
| +7.60% | -1.09% | +12.49% | +20.82% | 23.01B | |
| -0.24% | +2.97% | - | - | 14.82B | |
| +8.30% | +12.19% | +62.65% | +129.55% | 13.52B | |
| +0.70% | +2.97% | +93.04% | +93.04% | 12.56B | |
| +10.86% | +10.40% | +6.48% | -30.12% | 10.92B | |
| Average | +4.14% | +5.19% | +58.15% | +93.11% | 22.76B | |
| Weighted average by Cap. | +3.59% | +5.25% | +68.05% | +117.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.6B 8.63B 7.01B 6.56B 12.28B 814B 12.51B 84.24B 32.63B 401B 32.41B 31.71B 1,396B | 8.07B 9.17B 7.45B 6.97B 13.05B 864B 13.29B 89.5B 34.67B 426B 34.43B 33.69B 1,484B |
| Net income | 517M 587M 477M 446M 835M 55.32B 851M 5.73B 2.22B 27.29B 2.2B 2.16B 94.94B | 676M 768M 624M 583M 1.09B 72.39B 1.11B 7.5B 2.9B 35.71B 2.88B 2.82B 124B |
| Net Debt | 3.44B 3.91B 3.17B 2.97B 5.56B 369B 5.67B 38.15B 14.78B 182B 14.68B 14.36B 632B | 3.08B 3.5B 2.85B 2.66B 4.99B 330B 5.08B 34.19B 13.24B 163B 13.15B 12.87B 567B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-24 | €67.02 | +2.73% | 305,277 |
| 26-06-23 | €65.24 | +2.77% | 320,692 |
| 26-06-22 | €63.48 | +1.54% | 313,305 |
| 26-06-19 | €62.52 | -0.57% | 455,494 |
| 26-06-18 | €62.88 | +0.54% | 236,088 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions
